Medical Treatments

Hormone Therapy Gender-Affirming Care Gene Therapy Transgender Healthcare Surgical Procedures Pharmaceuticals Transgender Health Fertility Treatments Reproductive Health Pediatric Care Cancer Treatments Puberty Blockers Weight Loss Treatments Gender Dysphoria Chemotherapy Gender Transition Obesity Treatments Immunotherapy Gender-Affirming Treatments Pharmacology Obesity Management Innovative Therapies Hormonal Treatments Monoclonal Antibodies Experimental Treatments Stem Cell Therapy Transgender Care Transplants Medication Weight-Loss Drugs Hormonal Therapy Interventions Bariatric Surgery Assisted Reproductive Technology Hormonal Therapies Radiation Therapy In Vitro Fertilization Cosmetic Procedures Therapies Infertility Treatments Cell Therapy Aesthetic Medicine Pharmacotherapy Chronic Conditions Compression Therapy Injectable Medications Autoimmune Diseases FDA-Approved Drugs Medications Dialysis Drug Development Insulin Therapy Blood Storage Experimental Drugs Complement System Antibiotics Obstructive Sleep Apnea Cannabis Treatments Bladder Cancer Chelation Therapy Injections Wound Care Gender-affirming Care Weight Management Prescription Medications Emergency Abortions Leucovorin Cellular Therapy CDC Director Abortion Medications Dermatology Cancer Detection Anticoagulation Medications Procedures Antifungal Treatments High-Cost Treatments Hyperbaric Oxygen Therapy Cardiovascular Health Hair Removal Procedures Diabetes Weight-loss Medications Cosmetic Treatments Rare Diseases Eye Treatments Neurological Interventions Gender Dysphoria Treatments Experimental Therapies Gender Reassignment Iron Deficiency Anaemia Infusion Therapy Endoscopy Health Conditions Experimental Medicine Innovative Medications Cancer Therapy Hormone Testing Emergency Medicine Gender Transition Care Chronic Diseases Regulations

Samuel Monroe Jr. Faces Possible Vegetative State as Family Awaits More Scans

Medical teams say enlarged brain ventricles and uncontrolled seizures have produced worsening neurological injury that could make recovery unlikely.

Macrophage Cell Therapy Raises Four‑Year Transplant‑Free Survival in Cirrhosis

Hawley Urges House to Bar Federal Funds to Abortion and Gender‑Care Providers After Senate Defeat

Allogene Soars on Early ALPHA3 Readout Showing Strong MRD Edge and Clean Safety

Iovance Shares Hit Record After UBS Doubles Price Target

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

Vertex Heads Into Feb. 12 Earnings With Cautious Market After Mixed Year

Utah House Panel Takes Testimony on Bill to Curb Gender-Affirming Hormones for Minors

Federal Employees File EEOC Complaint as OPM Ends Coverage for Gender-Affirming Care

FDA Expands Addyi Use to Postmenopausal Women Under 65

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

FDA Panel Urges Looser Testosterone Rules, Including Descheduling and Broader Use

Michigan Medicine Halts Youth Gender Hormone Treatments After Federal Subpoenas

New Hampshire Legislature Sends Gender-Affirming Care Ban Bills to Governor

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP